Observational Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1823-1832
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1823
Table 1 Comparison of general information of ulcer group and non-ulcer group, n (%)
General Information
Ulcer group (n = 40)
Non-ulcer group (n = 156)
t/χ2 value
P value
Sex0.830.362
Male26 (65.00)89 (57.05)
Female14 (35.00)67 (42.95)
Age48.98 ± 8.2347.11 ± 9.021.2570.213
BMI22.25 ± 2.0121.83 ± 1.981.1830.242
Course of disease (yr)2.85 ± 0.482.66 ± 0.522.1950.032
History of H. pylori infection7 (17.50)11 (7.05)4.1680.041
Family history of GC8 (20.00)22 (14.10)0.8540.355
Drinking history9 (22.50)26 (16.67)0.7390.39
Smoking history24 (60.00)66 (42.31)4.0130.045
Comorbidities
Hypertension9 (22.50)26 (16.67)0.7390.39
Diabetes6 (15.00)22 (14.10)0.0210.885
Coronary heart disease7 (17.50)23 (14.75)0.1870.666
Residence0.1160.733
Rural25 (62.50)102 (65.38)
Town15 (37.50)54 (34.62)
Medication history
Aspirin12 (30.00)28 (17.95)2.8470.092
Clopidogrel 19 (47.50)27 (17.31)16.158< 0.001
Table 2 Comparison of pathological features of ulcer group and non-ulcer group, n (%)
Pathological features
Ulcer group (n = 40)
Non-ulcer group (n = 156)
t/χ2 value
P value
Lesion diameter (cm)4.40 ± 0.972.97 ± 0.628.871< 0.001
Number of tumors4.1850.041
Single shot18 (45.00)98 (62.83)
Multiple22 (55.00)58 (37.18)
Pathological type0.2680.605
Differentiated carcinoma19 (47.50)67 (42.95)
Undifferentiated carcinoma21 (52.50)89 (57.05)
Infiltration depth3.9880.046
Submucosa21 (52.50)55 (35.26)
Mucosal layer19 (47.50)101 (64.74)
Vascular invasion2 (5.00)6 (3.85)0.1080.742
Table 3 Comparison of endoscopic features of ulcer group and non-ulcer group, n (%)
Endoscopic features
Ulcer group (n = 40)
Non-ulcer group (n = 156)
χ2 value
P value
Lesion site2.1320.344
Upper 1/3 of stomach12 (30.00)61 (39.10)
1/3 of stomach20 (50.00)76 (48.72)
Lower 1/3 of stomach8 (20.00)19 (12.18)
Mucosal discoloration28 (70.00)63 (40.38)11.227< 0.001
Convergence folds28 (60.00)49 (31.41)19.877< 0.001
Lesion surface1.1050.576
Bulge11 (27.50)52 (33.33)
Flat15 (37.50)62 (39.74)
Sag14 (35.00)42 (26.93)
Table 4 Multivariate logistic regression analysis on the risk of ulcers after endoscopic submucosal dissection in early gastric cancer patients
Related indicator
β
SE
Wald
P value
OR
95%CI
Lower
Upper
Lesion diameter3.4170.64727.927< 0.00130.4908.584108.294
Clopidogrel medication history1.2680.6423.8990.0483.5541.00912.515
Convergent folds1.3510.6594.1950.0413.8601.06014.055
Mucosal discoloration1.1600.5843.9500.0473.1911.01610.021
Table 5 Evaluation of prediction model for ulcer occurrence after endoscopic submucosal dissection in early gastric cancer patients
Indicator
AUC
SD
P value
95%CI
Lower
Upper
Lesion diameter0.8850.036< 0.0010.8140.955
Clopidogrel medication history0.6510.0520.0030.5490.753
Mucosal discoloration0.6480.0480.0040.5540.742
Convergent folds0.6930.047< 0.0010.6010.785
Prediction model0.9160.0260.0000.8650.967